Stratipath and Roche partner to distribute AI-driven breast cancer diagnostics solution.

Stratipath and Roche have partnered to enhance access to AI-driven precision diagnostics for breast cancer patients. Roche will distribute Stratipath's EU-compliant solution, Stratipath Breast, which utilizes AI to assess risk levels in breast cancer tissue. This collaboration integrates with Roche's navify Digital Pathology software, streamlining diagnostics and offering a faster, more cost-effective alternative to traditional methods, ultimately improving patient care.

September 09, 2024
14 Articles